(Q77763078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Potential cost savings of erythropoietin administration in end-stage renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

5

Diane L Frankenfield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

9

Michael V Rocco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Denise M Hynes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Kevin T Stroupe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Joel W Greer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Domenic J Reda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

James S Kaufman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

William G Henderson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

William F Owen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Jay B Wish

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Jeffery Kang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

John R Feussner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

169-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

Erythropoietin for end-stage renal disease

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Subcutaneous erythropoietin therapy: efficacy and economic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Intravenous versus subcutaneous dosing of epoetin: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Must erythropoietin be injected by the subcutaneous route for every hemodialyzed patient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

Intravenous versus subcutaneous dosing of Epoetin alfa in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901103-2

10.1016/S0002-9343(01)01103-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11893342%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference